Trials / Recruiting
RecruitingNCT06811870
A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 161 (estimated)
- Sponsor
- Guangdong Provincial People's Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The goal of the study is to explore the efficacy and safety of hyperbaric oxygen in the neoadjuvant treatment of breast cancer patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | hyperbaric oxygen treatment | Patients who meet the inclusion criteria will be enrolled and given hyperbaric oxygen intervention, with a minimum of 5 hyperbaric oxygen treatments per chemotherapy cycle, one per day for 60-90 minutes, for a total of 30-40 hyperbaric oxygen treatments (100% oxygen at a pressure of 2.0 ATA). |
Timeline
- Start date
- 2025-02-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-02-06
- Last updated
- 2025-04-01
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06811870. Inclusion in this directory is not an endorsement.